Market Dynamics

Cardiogenic pulmonary oedema is usually cased by congestive heart failure and the percentage of congestive heart failure is increasing at an alarming rate. According to U.S. Department of Health & Human Services about 6.2 million adults in the United States have heart failure and in 2018, heart failure was mentioned on 379,800 death certificates. Government of developed countries is focused on development of advanced healthcare infrastructure by increasing the expenditure in order to provide better service. Awareness among heart patients is increasing and healthcare practitioner demand for advanced lung fluid monitor is increasing in order to lower heart failure. These collective events are major factors expected to drive the growth of global lung fluid monitor market. High penetration of smart devices, availability of high speed internet is helping private and public to deliver the better solutions to patients. For instance in 2020, Hadassah Medical Centre introduced a mobile application a smartphone app that identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates.  The major focus of the application is the system could be used to monitor heart failure patients at home.

Rapid technological advancements are taking place across the globe in the medical industry. Players are focused on product development their approach towards miniaturization of devices in order to deliver advanced care is gaining traction.

• In 2019, Medicure Inc. a global pharmaceutical company launched ReDSTM PRO system the next generation of lung fluid management technology for heart failure. The product launch helped the company to enhance the revenue and product portfolio.
• In 2019, ZOLL Medical Corporation a medical device manufacturing company launched its first patient prescription for the ZOLL µCor™ Heart Failure and Arrhythmia Management System (HFAMS), designed to help clinicians improve outcomes and reduce hospitalizations for heart failure patients with fluid management problems. This helped to company to enhance the customer base.

Collaborative efforts for R&D activities and introduction of new product are factors expected to augment the growth of lung fluid monitor market. In 2017, The Ohio State University doctors are testing a high-tech vest which measures fluid inside the lungs from outside a person's clothing. The SensiVest is an advanced technology that was miniaturized and put into a form that allows the radar to go through the chest wall and get an accurate measurement of water inside the lungs. Factors such as high cost of devices and stringent government regulations related to product approval are expected to hamper the growth of global lung fluid monitor market. In addition, lack of developed infrastructure for R&D activities in developing countries is expected to challenge the growth of target market. However, factors such as high investment for product development, increasing spending by the government of developing countries on infrastructure, and focus on delivering enhanced and cost-effective products are expected to create new opportunities for players operating in lung fluid monitor market. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of target market.

Segment Analysis by Region

The market in North America is expected to account for major revenue share in the global lung fluid monitor market due to rise in patient pool suffering from heart associated diseases. In addition, presence of large number of players operating in the country like US and focus on introduction of innovative solutions are factors positively impacting the growth of target market.

The market in Asia Pacific is expected to witness faster growth in the lung fluid monitor market due to high government spending on healthcare sector. In addition, favorable business policies by the government and emergence of small & mid-size enterprises with innovative solutions are expected to boost the growth of lung fluid monitor market.

Increasing merger & acquisition activities by the major players in order to enhance the business presence and revenue share is expected to support the growth of lung fluid monitor market.

Competitive Landscape               

The global lung fluid monitor market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report Coverage

Lung Fluid Monitor Market Segment Analysis, 2019

The global lung fluid monitor market is segmented into type and end use. The type segment is bifurcated into invasive, and non-invasive. Among type the non-invasive segment is expected to witness faster growth in the target market due to high penetration of smart phones and rapid advancements of smart monitoring devices. The end use segment is divided into hospitals and other. Among the end use hospital segment is expected to account for major revenue share in the target market due to high government spending on development of hospital infrastructure in order to deliver better and advanced care to patients. The players profiled in the report are Medtronic, Sensible Medical, ZOLL Medical Corporation, Medicure Inc., and Highmark Health.

Market Segmentation

Market By Type

Invasive
Non-invasive

Market By End Use

Hospitals
Others

Market By Geography

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa